Home/Filings/4/A/0000899243-21-049611
4/A//SEC Filing

Risico Joseph A 4/A

Accession 0000899243-21-049611

CIK 0001757715other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 5:00 PM ET

Size

18.2 KB

Accession

0000899243-21-049611

Insider Transaction Report

Form 4/AAmended
Period: 2021-03-15
Risico Joseph A
General Counsel
Transactions
  • Sale

    Common Stock

    2021-03-15$32.98/sh13,628$449,473178,924 total
  • Sale

    Common Stock

    2021-03-16$29.83/sh38,756$1,156,266140,129 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2021-03-15111,52426,937 total
    Exercise: $9.72Exp: 2028-12-28Common Stock (111,524 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-15$9.72/sh+111,524$1,084,013290,409 total
  • Sale

    Common Stock

    2021-03-15$31.84/sh41,319$1,315,589192,552 total
  • Sale

    Common Stock

    2021-03-15$31.14/sh56,538$1,760,497233,871 total
  • Sale

    Common Stock

    2021-03-15$33.66/sh39$1,313178,885 total
Footnotes (6)
  • [F1]The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.62 to $31.62, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.63 to $32.63, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.64 to $33.60, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.26 to $30.25, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]1/3rd of the number of shares subject to the option vested on October 11, 2019 and 1/36th of the number of shares subject to the option shall vest following each one month period thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
  • [F6]All of the unvested shares subject to the option shall vest upon either: (i) the accumulation, by means of any transaction or series of related transactions, whether directly or indirectly, beneficially or of record, by any individual and/or entity of more than 50% the outstanding shares of common stock of the Issuer, whether by merger, consolidation, sale or other transfer of shares of the Issuer's common stock, so long as the holders of the Issuer's common stock, immediately after such transaction or series of transactions, hold less than 50% of the common stock of the Issuer or the voting securities of the surviving or acquiring entity or (ii) a sale of all or substantially all of the assets of the Issuer, which may include a license transaction.

Issuer

Aterian, Inc.

CIK 0001757715

Entity typeother

Related Parties

1
  • filerCIK 0001778024

Filing Metadata

Form type
4/A
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 5:00 PM ET
Size
18.2 KB